Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study. [PDF]
Milhem MM +22 more
europepmc +1 more source
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy. [PDF]
Othus M +19 more
europepmc +1 more source
Visual Exploration and the Primate Hippocampal Formation. [PDF]
Buffalo EA.
europepmc +1 more source
The 2025 Oligo Meeting in Budapest: Highlights of the 21<sup>st</sup> annual meeting of the oligonucleotide therapeutics society. [PDF]
Godinho BMDC, Guo S.
europepmc +1 more source
Contemporary outcomes in no-option chronic limb-threatening ischemia. [PDF]
Dua A +13 more
europepmc +1 more source
Long-Term Experiences of Health Care Providers Using Iris Scanning as an Identification Tool in a Vaccine Trial in the Democratic Republic of the Congo: Qualitative Study. [PDF]
Zola Matuvanga T +14 more
europepmc +1 more source
Subacute Thyroiditis Masquerading as Fever of Unknown Origin. [PDF]
Gafoor S +4 more
europepmc +1 more source
Patient-Perceived Overall Side Effect Bother at and After Cancer Treatment Discontinuation: An Analysis Using Commercial Cancer Trial Data. [PDF]
Roydhouse J +8 more
europepmc +1 more source
A fungal nightmare: A rare and deadly presentation of disseminated histoplasmosis. [PDF]
Naji A +8 more
europepmc +1 more source

